MicroPort participated in the round through a partnership deal that gave it marketing rights for Rapid's endovascular devices in China.

Israel-based endovascular device maker Rapid Medical has collected $20m in a series C round co-led by medical device manufacturer MicroPort Scientific Corporation and investment firm Jam Capital Partners.

The round also included RocSon Medtech Fund and Agate JT, a partnership between JT Capital and Agate Medical Investments.

Founded in 2008, Rapid Medical is developing systems to assist with endovascular treatments, minimally invasive procedures that are conducted inside the blood vessels.

The company’s products include a device to retrieve clots in patients…